Royalty Pharma Acquires Cliramitug Royalty Rights from Neurimmune
NEW YORK, July 22, 2026 Royalty Pharma plc has announced the acquisition of a portion of Neurimmune’s royalty interest...
Life Sciences
Advertisement
Repligen’s $1.5B BioLife Deal Expands CGT Portfolio
WALTHAM, Mass. & BOTHELL, Wash., July 22, 2026 Repligen Corporation has announced a definitive agreement to acquire BioLife Solutions...
Bayer Secures €3 Billion Apollo Investment for LARC Business
LEVERKUSEN, Germany, July 10, 2026 Bayer AG has announced a landmark €3.0 billion equity investment agreement with global asset...
OTR Therapeutics and LG Chem Partner to Advance Oncology Therapies
SHANGHAI, China, July 8, 2026 OTR Therapeutics and LG Chem Life Sciences have announced a strategic collaboration to accelerate...
RoosterBio and Applied StemCell Partner to Scale iPSC Manufacturing
MILPITAS, Calif. & FREDERICK, Md., July 8, 2026 RoosterBio and Applied StemCell (ASC) have announced a strategic partnership to...
Advertisements
Clarivate Sells Life Sciences Unit to Altaris for $600M
LONDON, July 6, 2026 Clarivate Plc has announced a definitive agreement to sell its Life Sciences & Healthcare (LS&H)...
BillionToOne Northstar Response® Advances Cancer Monitoring
MENLO PARK, Calif., June 29, 2026 BillionToOne has announced the publication of a peer-reviewed clinical study demonstrating that its...
Inductive Bio Brings AI-Powered ADMET Models to Claude
NEW YORK, June 30, 2026 Inductive Bio, Inc. has announced its integration into Anthropic’s Connector Ecosystem for Life Sciences,...
Evaluate Wins AI Breakthrough Award for Ask Ella Platform
LONDON, June 25, 2026 Evaluate, a Norstella company and a leading provider of pharmaceutical market intelligence, has been recognized...
Merck KGaA to Acquire Bio-Techne in $11.3B Life Science Deal
DARMSTADT, Germany & MINNEAPOLIS, June 25, 2026 Merck KGaA, Darmstadt, Germany has signed a definitive agreement to acquire Bio-Techne...
Advertisement
